Patent number: 9023609
Abstract: The present invention reveals a strong correlation between FGL-2 prothrombinase activity levels and the presence of a malignant proliferative disorder in a subject. Thus, the present invention provides FGL-2 prothrombinase activity as a diagnostic tool for malignancy.
Type: Grant
Filed: July 11, 2011
Issued: May 5, 2015
Assignees: Mor Research Applications Ltd., Ramot at Tel-Aviv University Ltd.
Inventors: Aida Inbal, Esther Rabizadeh